Horizon Pharma Plc – Strategy, SWOT and Corporate Finance Report

Horizon Pharma Plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company

Key Highlights

Horizon Pharma plc (Horizon Pharma) is a pharmaceutical company which develops and commercializes medical products for the treatment of pain, arthritis and inflammatory diseases. It markets medicines through its orphan, primary care and rheumatology business units. The company’s marketed products include Actimmune, Buphenyl, Duexis, Krystexxa, Migergot, Pennsaid 2%, Procysbi, Quinsair, Ravicti, Rayos and Vimovo. Horizon Pharma provides products and services to patients and healthcare professionals in the US. The company operates through offices in the US, Switzerland, the Netherlands and Germany. Horizon Pharma is headquartered in Dublin, Ireland.

Scope

Detailed information on Horizon Pharma Plc required for business and competitor intelligence needs

A study of the major internal and external factors affecting Horizon Pharma Plc in the form of a SWOT analysis

An in-depth view of the business model of Horizon Pharma Plc including a breakdown and examination of key business segments

News about Horizon Pharma Plc, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Horizon Pharma Plc and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Horizon Pharma Plc as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Horizon Pharma Plcs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Acorda Therapeutics Inc

Sucampo Pharmaceuticals Inc

Orexigen Therapeutics Inc

Arena Pharmaceuticals Inc

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Horizon Pharma Plc - Key Facts

Horizon Pharma Plc - Key Employees

Horizon Pharma Plc - Key Employee Biographies

Horizon Pharma Plc - Major Products and Services

Horizon Pharma Plc - History

Horizon Pharma Plc - Company Statement

Horizon Pharma Plc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 Company Analysis

Company Overview

Horizon Pharma Plc - Business Description

Business Segment: Orphan and Rheumatology

Overview

Performance

Business Segment: Primary Care

Overview

Performance

Geographical Segment: Rest of World

Performance

Geographical Segment: United States

Performance

Horizon Pharma Plc - Corporate Strategy

Horizon Pharma Plc - SWOT Analysis

SWOT Analysis - Overview

Horizon Pharma Plc - Strengths

Horizon Pharma Plc - Weaknesses

Horizon Pharma Plc - Opportunities

Horizon Pharma Plc - Threats

Horizon Pharma Plc - Key Competitors

Section 3 Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 Company’s Lifesciences Financial Deals and Alliances

Horizon Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Horizon Pharma Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Horizon Pharma Plc, Recent Deals Summary

Section 5 Company’s Recent Developments

May 08, 2019: Horizon Therapeutics announces strong first-quarter 2019 financial results

Apr 11, 2019: Horizon Pharma named one of the 2019 best workplaces in health care and Biopharma by FORTUNE and Great Place to Work

Mar 18, 2019: Horizon Pharma Wins PR News CSR Award for Partnership with Perspectives Math and Science Academy

Feb 27, 2019: Horizon Pharma reports record fourth-quarter and full-year 2018 net sales driven by orphan and rheumatology segment; announces full-year 2019 guidance

Nov 07, 2018: Horizon pharma reports third-quarter net sales growth of 20 percent driven by Orphan and Rheumatology net sales growth of 25 percent

Nov 02, 2018: The Chicago Tribune Names Horizon Pharma a 2018 top workplace

Oct 25, 2018: Horizon Pharma presents multiple retrospective analyses showing kidney transplant recipients have higher rates of gout and increased disease severity

Oct 22, 2018: Horizon Pharma announces multiple data presentations highlighting the growing burden of uncontrolled gout at the 2018 ACR/ARHP Annual Meeting

Sep 27, 2018: The north american pediatric renal trials and collaborative studies and Horizon Pharma announce new long-term cystinosis registry

Aug 08, 2018: Horizon pharma reports record quarterly net sales for orphan and rheumatology segment; increases full-year 2018 adjusted EBITDA guidance; implements new company operating structure to enhance focus on rare diseases

Section 6 Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Horizon Pharma Plc, Key Facts

Horizon Pharma Plc, Key Employees

Horizon Pharma Plc, Key Employee Biographies

Horizon Pharma Plc, Major Products and Services

Horizon Pharma Plc, History

Horizon Pharma Plc, Subsidiaries

Horizon Pharma Plc, Key Competitors

Horizon Pharma Plc, Ratios based on current share price

Horizon Pharma Plc, Annual Ratios

Horizon Pharma Plc, Annual Ratios (Cont…1)

Horizon Pharma Plc, Annual Ratios (Cont…2)

Horizon Pharma Plc, Interim Ratios

Horizon Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Horizon Pharma Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Horizon Pharma Plc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Horizon Pharma Plc, Performance Chart (2014 – 2018)

Horizon Pharma Plc, Ratio Charts

Horizon Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Horizon Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports